WINT · Windtree Therapeutics Inc /De/ · Debt
$0.14
+0.03 (+24.55%)
At close · Aug 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 19, 2025
Substantial doubt about the company's ability to continue as a going concern.
“We do not have sufficient cash and cash equivalents as of the date of this Quarterly Report on Form 10-Q to support our operations for at least the 12 months following the date that the financial statements are issued. These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 19, 2025
Market Cap
$3,370
Shares
33.71M
Volume · Aug 21
6.7M
Avg daily vol (3M)
12.02M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2025-09-30 | USD 544,000 | 10-Q filed 2025-11-19 |
| Current portion of convertible notes payable | 2025-09-30 | USD 2,590,000 | 10-Q filed 2025-11-19 |
| Noncurrent operating lease liabilities | 2025-09-30 | USD 240,000 | 10-Q filed 2025-11-19 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.